Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2686 AL 2700

Current Alzheimer disease research highlights: evidence for novel risk factors

Brenowitz WD, Xiang Y, McEvoy CT, Yang C, Yaffe K, Le WD, Leng Y.

Chin Med J (Engl). 2021 Sep 9;134(18):2150-2159. doi: 10.1097/CM9.0000000000001706.

Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases?

Ribeiro R, Santos AC, Calazans MO, De Oliveira ACP, Vieira LB.

Nutr Neurosci. 2022 Nov;25(11):2442-2457. doi: 10.1080/1028415X.2021.1972514. Epub 2021 Sep 11.

The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target

Gao F, Liu T, Tuo M, Chi S.

Neurosci Lett. 2021 Nov 20;765:136247. doi: 10.1016/j.neulet.2021.136247. Epub 2021 Sep 14.

Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review

Puga AM, Ruperto M, Samaniego-Vaesken ML, Montero-Bravo A, Partearroyo T, Varela-Moreiras G.

Nutrients. 2021 Aug 26;13(9):2966. doi: 10.3390/nu13092966.

Editorial: How Will Aducanumab Approval Impact AD Research?

Weiner MW, Aisen PS, Beckett LA, Green RC, Jagust W, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ.

J Prev Alzheimers Dis. 2021;8(4):391-392. doi: 10.14283/jpad.2021.46.

Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

Lowe SL, Duggan Evans C, Shcherbinin S, Cheng YJ, Willis BA, Gueorguieva I, Lo AC, Fleisher AS, Dage JL, Ardayfio P, Aguiar G, Ishibai M, Takaichi G, Chua L, Mullins G, Sims JR.

J Prev Alzheimers Dis. 2021;8(4):414-424. doi: 10.14283/jpad.2021.56.

Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives

Usman MB, Bhardwaj S, Roychoudhury S, Kumar D, Alexiou A, Kumar P, Ambasta RK, Prasher P, Shukla S, Upadhye V, Khan FA, Awasthi R, Shastri MD, Singh SK, Gupta G, Chellappan DK, Dua K, Jha SK, Ruokolainen J, Kesari KK, Ojha S, Jha NK.

J Prev Alzheimers Dis. 2021;8(4):534-551. doi: 10.14283/jpad.2021.52.

Effects and mechanisms of natural products on Alzheimer's disease

Yang Z, Zhou DD, Huang SY, Fang AP, Li HB, Zhu HL.

Crit Rev Food Sci Nutr. 2023;63(18):3168-3188. doi: 10.1080/10408398.2021.1985428. Epub 2021 Oct 6.

Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD)

Cohen LM, Ash E, Outen JD, Vandrey R, Amjad H, Agronin M, Burhanullah MH, Walsh P, Wilkins JM, Leoutsakos JM, Nowrangi MA, Harper D, Rosenberg PB, Forester BP.

Int Psychogeriatr. 2024 Dec;36(12):1245-1250. doi: 10.1017/S1041610221001150. Epub 2021 Oct 11.

Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ(1-)(40) injection in ovariectomized Alzheimer's disease model rats

Xie Y, Yan B, Hou M, Zhou M, Liu C, Sun M, He K, Fang C, Chen Y, Huang L.

Pharm Biol. 2021 Dec;59(1):1402-1414. doi: 10.1080/13880209.2021.1990353.

Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1

Liu XY, Zhang N, Zhang SX, Xu P.

Eur J Neurosci. 2021 Nov;54(10):7749-7769. doi: 10.1111/ejn.15502. Epub 2021 Nov 7.

Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease

Flores-Clemente C, Nicolás-Vázquez MI, Mera Jiménez E, Hernández-Rodríguez M.

Biomolecules. 2021 Sep 26;11(10):1408. doi: 10.3390/biom11101408.

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease

Liu CS, Herrmann N, Song BX, Ba J, Gallagher D, Oh PI, Marzolini S, Rajji TK, Charles J, Papneja P, Rapoport MJ, Andreazza AC, Vieira D, Kiss A, Lanctôt KL.

BMC Geriatr. 2021 Dec 4;21(1):677. doi: 10.1186/s12877-021-02636-6.

Cardiac Biomarkers in Stroke, Alzheimer's Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations

Khan S, Kamal MA.

CNS Neurol Disord Drug Targets. 2021;20(8):687-693. doi: 10.2174/1871527319666201005171003.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias